GSK3888550A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3888550A, covering 2020-04-15 to 2020-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women [Phase 1]